These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1117518)

  • 41. Irradiation synovectomy: clinical study of 67 knee effusions intra-articularly irradiated with 90 Y resin.
    Jalava S
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):395-401. PubMed ID: 4198301
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnosis and therapy of advanced bladder carcinoma].
    Bandhauer K
    Helv Chir Acta; 1973 Sep; 40(4):421-6. PubMed ID: 4201823
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
    Herr HW; Schwalb DM; Zhang ZF; Sogani PC; Fair WR; Whitmore WF; Oettgen HF
    J Clin Oncol; 1995 Jun; 13(6):1404-8. PubMed ID: 7751885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancer.
    Cooke PW; Dunn JA; Latief T; Bathers S; James ND; Wallace DM
    Eur Urol; 2000 Sep; 38(3):279-86. PubMed ID: 10940701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term effects on recurrence and mortality in superficial urothelioma of the bladder treated with endovesical chemotherapy].
    Ferraris V; Serao A; Buffa G
    Minerva Urol Nefrol; 1999 Jun; 51(2):95-101. PubMed ID: 10429419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.
    Cheng CW; Chan PS; Chan LW; Chan CK; Ng CF; Lai MM
    Int Braz J Urol; 2005; 31(3):204-11. PubMed ID: 15992422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results.
    Hurle R; Manzetti A; Losa A; Micheli E; Ranieri A; Chinaglia D; Lembo A
    Urol Int; 1998; 61(4):220-6. PubMed ID: 10364753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The treated natural history of high risk superficial bladder cancer: 15-year outcome.
    Cookson MS; Herr HW; Zhang ZF; Soloway S; Sogani PC; Fair WR
    J Urol; 1997 Jul; 158(1):62-7. PubMed ID: 9186324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A long history of bladder polyposis].
    Abbes M; Boyer R; Bonhomme L; Richelme H
    J Urol Nephrol (Paris); 1973; 79(1):161-5. PubMed ID: 4724365
    [No Abstract]   [Full Text] [Related]  

  • 55. Expectant management of small, recurrent, noninvasive papillary bladder tumors.
    Soloway MS; Bruck DS; Kim SS
    J Urol; 2003 Aug; 170(2 Pt 1):438-41. PubMed ID: 12853794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Interstitial radioactive gold implantation in treatment of bladder cancer].
    Verduyn H; Vereecken RL; Van De Merckt J
    Acta Urol Belg; 1971 Jan; 39(1):44-9. PubMed ID: 5581469
    [No Abstract]   [Full Text] [Related]  

  • 57. High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG).
    Pansadoro V; Emiliozzi P; depaula F; Scarpone P; Pizzo M; Federico G; Martini M; Pansadoro A; Sternberg CN
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):223-7. PubMed ID: 16767936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival of patients with superficial bladder cancer after treatment: a 10-year retrospective follow-up study.
    Uchida K; Shimazui T; Nemoto R; Kano S; Koiso K
    Jpn J Clin Oncol; 1984 Sep; 14(3):369-77. PubMed ID: 6482017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Observations on definitive cobalt 60 radiation for cure in bladder carcinoma: 15-year followup.
    Cummings KB; Taylor WJ; Correa RJ; Gibbons RP; Mason JT
    J Urol; 1976 Feb; 115(2):152-4. PubMed ID: 765497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical study of preoperative radiotherapy of bladder cancer].
    Shimada H; Imanaka K; Hashimura T; Hirota S; Yonezawa K; Soezima T; Izumiyama K; Kono M; Goji K; Hamami M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1385-90. PubMed ID: 2212829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.